T 1532/09 of 07.10.2010
- European Case Law Identifier
- ECLI:EP:BA:2010:T153209.20101007
- Date of decision
- 7 October 2010
- Case number
- T 1532/09
- Petition for review of
- -
- Application number
- 01122359.1
- IPC class
- A61M 15/00
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Metered dose inhaler for fluticasone propionate
- Applicant name
- GlaxoSmithKline LLC
- Opponent name
- Opponent I : 3M Innovative Properties Company
Opponent II : NORTON HEALTHCARE LIMITED
Opponent III: Chiesi Farmaceutici S.p.A. - Board
- 3.2.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 104European Patent Convention Art 54European Patent Convention Art 56Rules of procedure of the Boards of Appeal Art 15(3)Rules of procedure of the Boards of Appeal Art 16(1)(c)Rules of procedure of the Boards of Appeal Art 16(1)(e)
- Keywords
- Novelty (all requests - yes)
Inventive step (all requests - no)
Apportionment of costs (no) - Catchword
- -
- Cited cases
- -
- Citing cases
- T 1309/10
ORDER
For these reasons it is decided that:
The appeal is dismissed.